Skip to content

Clinical trials

Phase 2 Leukemia-Lymphoma, Adult T-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia-Lymphoma, Adult T-Cell Phase: Phase 2 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20081
20091
20102
20122
20161
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kyowa Kirin Co., Ltd.2
National Cancer Institute (NCI)2
Actuate Therapeutics Inc.1
Carlos Brites1
Celgene1
Columbia University1
Kyowa Kirin, Inc.1
Novartis Pharmaceuticals1
University of Miami1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia-Lymphoma, Adult T-Cell11
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma2
Bone Neoplasms1
Breast Neoplasms1
Colorectal Neoplasms1
Glioma1
HTLV-I Infections1
Hereditary Sensory and Autonomic Neuropathies1
Kidney Neoplasms1
Lung Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.